Abstract
Summary: Diabetes mellitus (DM) is a disease condition characterised by hyperglycemia; free radical and abnormal haematological indices. Vitamin C can reduce free radical generation and ameliorate adverse conditions of diabetes mellitus. The aim of the present study is to investigate the effect of vitamin C on platelet aggregation and electrolyte levels in Type 1 DM. Male Wistar rats were divided into four groups namely control, DM, DM +Vitamin C and Vitamin C groups. Rats were made diabetic with a single dose of streptozotocin (65 mg/kg) intraperitoneally. Vitamin C was administered orally to diabetic and normal rats at 200 mg/kg body weight for 28 days. Blood samples were analyzed for hematological parameters, platelet aggregation, and serum electrolyte levels. Blood glucose in DM+ Vitamin C group (9.9 ± 1.8 mmol/L) was significantly reduced (p<0.01) compared to DM group (32.2 ± 2.1 mmol/L) and significantly higher (p<0.05) than control (4.4 ± 0.8 mmol/L). Haemoglobin (Hb) concentration in DM group (12 ± 0.1 g/dL) was significantly reduced (p<0.01) when compared with control groups (14 ± 0.24 g/dL) and significantly increased (p<0.05) in the DM+vitamin C group (13.5 ± 0.5 g/dL) compared with the diabetic group. The mean corpuscular volume values in DM (68.66 ± 0.5 fL) and DM+vitamin C groups (68.11 ± 0.4 fL) were significantly higher (p<0.01) than the control (59.49 ± 0.5fL). Platelet count in DM group (523 ± 8.5 x109/L) was significantly raised (p<0.01) when compared to control (356 ± 6.2 x109/L) and significantly reduced (p<0.01) in DM+ vitamin C-treated group (385 ± 7.8 x109/L) compared with DM group. Platelet aggregation and serum sodium/potassium ratios was significantly reduced (p<0.01) in DM+vitamin C compared with DM group. These results suggest that oral vitamin C administration increases haemoglobin, reduced plasma glucose level, platelet count, serum sodium/potassium ion ratio and inhibits platelet aggregation in streptozotocin-induced DM in rats.
References
Afkhami-Ardekani M, and Shojaoddiny-Ardekani A. (2007). Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res. 126: 471-474.
Alsaif, M. A. (2009). Combined treatment of rutin and vitamin C improves the antioxidant status in streptozotocin-induced diabetic rats. J Med Sci. 9: 1-9.
Al-Shamsi, M., Amin, A., and Adeghate, E. (2007). The effect of vitamin C on the metabolic parameters of experimental diabetes mellitus. Am. J. Pharmacol. Toxicol. 2: 4-9.
Al-Shamsi, M., Amin, A., Adeghate, E. (2006). Effect of vitamin C on liver and kidney functions in normal and diabetic rats. Ann. N.Y. Acad. Sci. 1084: 371-390.
Atanasova, B., Mudway, I. S., Laftah, A. H., Latunde-Dada, G. O., McKie, A. T., Peters, T. J., Tzatchev, K. N., Simpson, R. J. (2004). Duodenal ascorbate levels are changed in mice with altered iron metabolism. J. Nutr. 134: 501-505.
Barnett, A. H. (1993). Origin of the microangiopathic changes in diabetes. Eye 7: 218-222.
Bosman, D. R., Winkler, A. S., Marsden, J. T., Macdougall, I. C., Watkins, P. J. (2001). Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 24: 495-499.
Brink, S. J. (1999). Diabetic ketoacidosis. Acta Pediatr. 88: 14-24.
Browne, D., Meeking, D., Shaw, K., Cummings, M. (2003). Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes - pathogenesis and identification. Br. J. Diabetes Vasc. Dis. 3: 27-34.
Carlotti, A. P. 1., St George-Hyslop, C., Bohn, D., Halperin, M. L. (2013). Hypokalemia during treatment of diabetic ketoacidosis: clinical evidence for an aldosterone-like action of insulin. J. Pediatr.63: 207-212.
Castro, M. A., Angulo, C., Brauchi, S., Nualart, F., Concha, I. I. (2008). Ascorbic acid participates in a general mechanism for concerted glucose transport inhibition and lactate transport stimulation. Pflugers Arch. 457: 519-528.
Comazzi, S., Spagnolo, V., Bonfanti, U. (2004). Erythrocyte changes in canine diabetes mellitus: In vitro effects of hyperglycaemia and ketoacidosis. Comp. Clin. Pathol. 12: 199-205.
Cunningham, J. J. (1988). Altered vitamin C transport in diabetes mellitus. Med. Hypotheses 26: 263-265.
Dakhale, G. N., Chaudhari, H. V., Shrivastava, M. (2011). Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv. Pharmacol. Sci. 2011:195271.
Davidson, R. J. L., Evan-Wong, L. A., Stowers, J. M. (1981).The mean red cell volume in diabetes mellitus. Diabetologia 20: 583-584.
Eteng, M. U., Ibekwe, H. A., Amatey, T. E., Bassey, B. J., Uboh, F. U., Owu, D. U. (2006). Effect of oral vitamin C on serum lipid and electrolytes profile of albino Wistar rats. Niger. J. Physiol. Sci.21: 15-19.
Farvid, M. S., Jalali, M., Siassi, F., Saadat, N., Hossein, M. (2004). The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes. J. Am. Col. Nutr. 23: 272-279.
Field, C. J., Johnson, I. R., Schley, P. D. (2002). Nutrients and their role in host resistance to infection. J. Leukoc. Biol.71:16-32.
Fraser, R. C., Pavlovic, S., Kurahara, C. G., Murata, A., Peterson, N. S., Taylor, K. B., Feigen, G. A. (1980). The effect of variations in vitamin C intake on the cellular immune response of guinea pigs. Am. J. Clin. Nutr.33: 839-847.
Gutierrez, A. D., Duran-Valdez, E., Robinson, I., de Serna, D. G., Schade, D. S. (2013). Does short-term vitamin C reduce cardiovascular risk in type 2 diabetes? Endocr. Pract. 19: 785-791.
Hall, J. A., Chinn, R. M., Vorachek, W. R., Gorman, M. E., Greitl, J. L., Joshi, D. K., Jewell, D. E. (2011). Influence of dietary antioxidants and fatty acids on neutrophil mediated bacterial killing and gene expression in healthy Beagles. Vet. Immunol. Immunopathol. 139: 217-228.
Hasslacher, C., Collenberg, E., Mocks, J. (2010). Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy. Exp. Clin. Endocrinol. Diabetes. 18: 341-345.
Iqbal, K., Khan, A., Khattak, M.M.A.K.(2004). Biological significance of ascorbic acid (vitamin c) in human health - A review. Pak. J. Nutr. 3: 5-13.
Jaja, S. I., Ikotun, A. R., Gbenebitse, S., Temiye, E. O.(2002). Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation. J. Trop. Pediatr.48: 366-370.
Li, Y., Ma, A., Sun, Y., Liang, H., Wang, Q., Yi, X., Han, X. (2009). Magnesium status and dietary intake of mid-old people in a rural area of China. Magnes. Res.22: 66-71.
Morales-Ramirez, P., Mendiola-Cruz, M. T., Cruz-Vallejo, V. (1998). Effect of vitamin C or beta-carotene on SCE induction by gamma rays in radiosensitized murine bone marrow cells in vivo. Mutagenesis 13: 139-144.
Mullan, B. A., Young, I. S., Fee, H., McCance, D. R. (2002). Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40: 804-809.
Obineche, E., Chandranath, I., Adeghate, E., Benedict, S., Fahim, M., Adem, A. (2006). Alterations in atrial natriuretic peptide and its receptor levels in long term, streptozotocin-induced, diabetes in rats. Ann. N. Y. Acad. Sci. 1084: 223–234.
Onwuliri, V. A., Bitrus, S., Puppet, F., Maduka, H. C.C. (2004). Blood lipids and electrolyte profiles of male and female diabetics in Plateau State Nigeria. J. Medical Sci 4: 221-224.
Owu, D. U., Antai, A. B., Udofia, K. H., Obembe, A. O., Obasi, K. O., Eteng, M. U. (2006). Vitamin C improves basal metabolic rate and lipid profile in alloxan-induced diabetes mellitus in rats. J. Biosci. 31: 575-579.
Owu, D. U., Obembe, A. O., Nwokocha, C. R., Edoho, I. E., Osim, E. E. (2012). Gastric ulceration in diabetes mellitus: protective role of vitamin C. ISRN Gastroenterology 2012, Article ID 362805, 7 pages.
Pak, S. I. (2000). The clinical implication of sodium-potassium ratios in dogs. J. Vet. Sci. 1: 61-65.
Pignatelli, P., Sanguigni, V., Paola, S., Lococo, E., Lenti, L., Violi, F. (2005). Vitamin C inhibits platelet expression of CD40 ligand. Free Radical Biol. Med. 38:1662-1666.
Rabble, G. R., Atherton, J. O., Stuart, H. B., Wong, O. (1996). Anaemia due to erythropoietin concentration in diabetic patient. Environ Health Perspect 1996, 104: 229-233.
Ramakrishna, V., Jailkhani, R. (2007). Evaluation of oxidative stress in insulin dependent diabetes mellitus (IDDM) patients. Diagn. Pathol.1: 2:22.
Rao, G. M. (1992). Serum electrolytes and osmolality in diabetes mellitus. Indian J. Med. Sci. 46: 301-303.
Ritz, E. (2006). Anemia and diabetic nephropathy. Curr. Diabetes Rep. 6: 469-472.
Sjogren, A., Floren, C. H., Nilsson, A. (1998). Magnesium, potassium and zinc deficiency in subjects with type 2 diabetes mellitus. Acta Med. Scand.224: 461-466.
Skowasch, D., Tuleta, I., Viktor, A., Bauriedel, G., Nickenig, G. (2009). Diabetes mellitus is associated with increased ex vivo-platelet aggregation and decreased response to aspirin-antithrombotic potential of ACE-inhibitors and AT1-antagonists. Platelets. 20: 358-359.
Skrha, J., Prazny, M., Hilgertova, J., Kvasnicka, J.
Kalousova, M., Zima, T. (2007). Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur. J. Clin. Pharmacol. 63: 1107-1114.
Thomas, M. C., MacIsaac, R. J., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. (2004). The burden of anaemia in type 2 diabetes and the role of nephropathy: A cross-sectional audit. Nephrol. Dial. Transplant.19: 1792-1797.
Wilkinson, I. B., Megson, I. L., MacCallum, H., Sogo, N., Cockcroft, J. R., Webb, D. J. (1999). Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc. Pharmacol.34: 690-693.
Wu, K. K., Hoak, J. C. (1974). A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 2: 924-926.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.